Literature DB >> 29491338

[National Trends in the Distribution of Candida Species Causing Candidemia in Japan from 2003 to 2014].

Hiroshi Kakeya1, Koichi Yamada1, Yukihiro Kaneko2, Katsunori Yanagihara3, Kazuhiro Tateda4, Shigefumi Maesaki5, Yoshio Takesue6, Kazunori Tomono7, Jun-Ichi Kadota8, Mitsuo Kaku9, Yoshitsugu Miyazaki10, Katsuhiko Kamei11, Kazutoshi Shibuya12, Yoshitiho Niki13, Minoru Yoshida14, Yoshihiro Sei15.   

Abstract

The Epidemiological Investigation Committee for Human Mycoses in Japan performed a retrospective epidemiological survey of candidemia and causative Candida species. Data from 2003 to 2014 were collected from 10 Japanese university hospitals. A total of 328,318 blood cultures were included. The prevalence of fungi in all cultures and in positive cultures were 0.58±0.09% and 4.46±0.66%, respectively. Among the results that were positive for Candida species (N=1,921), Candida albicans was the most common species (39.5%) and was followed by Candida parapsilosis (23.3%), Candida glabrata (13.2%), Candida tropicalis (7.1%), Candida krusei (3.2%), and others (13.7%). During the last 6 years, the frequency of C. albicans has significantly decreased in Japan, while that of C. glabrata has increased. Additional surveys are needed to continuously monitor the trends in the distribution of candidemia.

Entities:  

Keywords:  Candida; Japan; blood stream infections; candidemia

Mesh:

Year:  2018        PMID: 29491338     DOI: 10.3314/mmj.17-00014

Source DB:  PubMed          Journal:  Med Mycol J


  10 in total

Review 1.  Candida parapsilosis: from Genes to the Bedside.

Authors:  Renáta Tóth; Jozef Nosek; Héctor M Mora-Montes; Toni Gabaldon; Joseph M Bliss; Joshua D Nosanchuk; Siobhán A Turner; Geraldine Butler; Csaba Vágvölgyi; Attila Gácser
Journal:  Clin Microbiol Rev       Date:  2019-02-27       Impact factor: 26.132

2.  Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan.

Authors:  Hazim O Khalifa; Teppei Arai; Hidetaka Majima; Akira Watanabe; Katsuhiko Kamei
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

3.  Candidemia in patients with head and neck cancer: mortality and a novel risk factor.

Authors:  Kensuke Uraguchi; Takuma Makino; Shin Kariya; Youhei Noda; Hidenori Marunaka; Akira Doi; Kenichi Kozakura; Soshi Takao; Mizuo Ando
Journal:  Support Care Cancer       Date:  2022-04-06       Impact factor: 3.603

4.  A longitudinal study of Candida bloodstream infections in a Japanese university hospital: species distribution, drug susceptibility, clinical features, and mortality predictors.

Authors:  Hitoshi Tsukamoto; Takashi Higashi; Takaaki Kodawara; Kyohei Watanabe; Yukio Hida; Hiromichi Iwasaki; Nobuyuki Goto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-09-26       Impact factor: 5.103

5.  Modified Pitt bacteremia score for predicting mortality in patients with candidaemia: A multicentre seven-year retrospective study conducted in Japan.

Authors:  Nana Nakada-Motokawa; Taiga Miyazaki; Takashi Ueda; Yuka Yamagishi; Koichi Yamada; Hideki Kawamura; Hiroshi Kakeya; Hiroshi Mukae; Hiroshige Mikamo; Yoshio Takesue; Shigeru Kohno
Journal:  Mycoses       Date:  2021-10-23       Impact factor: 4.931

6.  Successful Treatment of Refractory Candidal Granuloma by Itraconazole and Terbinafine in Combination with Hyperthermia and Cryotherapy.

Authors:  Heli Yang; Xiaoxi Xu; Xin Ran; Yuping Ran
Journal:  Dermatol Ther (Heidelb)       Date:  2020-05-14

7.  Surveillance study of the prevalence, species distribution, antifungal susceptibility, risk factors and mortality of invasive candidiasis in a tertiary teaching hospital in Southwest China.

Authors:  Zhang-Rui Zeng; Gang Tian; Yin-Huan Ding; Kui Yang; Jin-Bo Liu; Jian Deng
Journal:  BMC Infect Dis       Date:  2019-11-07       Impact factor: 3.090

8.  Machine-learning based prediction of prognostic risk factors in patients with invasive candidiasis infection and bacterial bloodstream infection: a singled centered retrospective study.

Authors:  Yaling Li; Yutong Wu; Yali Gao; Xueli Niu; Jingyi Li; Mingsui Tang; Chang Fu; Ruiqun Qi; Bing Song; Hongduo Chen; Xinghua Gao; Ying Yang; Xiuhao Guan
Journal:  BMC Infect Dis       Date:  2022-02-13       Impact factor: 3.090

9.  Distribution, trends, and antifungal susceptibility of Candida species causing candidemia in Japan, 2010-2019: A retrospective observational study based on national surveillance data.

Authors:  Toshiki Kajihara; Koji Yahara; Minoru Nagi; Norikazu Kitamura; Aki Hirabayashi; Yumiko Hosaka; Masahiro Abe; Yoshitsugu Miyazaki; Motoyuki Sugai
Journal:  Med Mycol       Date:  2022-09-29       Impact factor: 3.747

10.  Antifungal susceptibility profile of Candida clinical isolates from 22 hospitals of São Paulo State, Brazil.

Authors:  D K B Rodrigues; L X Bonfietti; R A Garcia; M R Araujo; J S Rodrigues; V M F Gimenes; M S C Melhem
Journal:  Braz J Med Biol Res       Date:  2021-06-14       Impact factor: 2.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.